ArticleThe relation between serum osteoprotegerin level and coronary artery calcification in type 2 diabetes mellitus patients
ArticleThe relation between serum osteoprotegerin level and coronary artery calcification in type 2 diabetes mellitus patients
ArticleStudy of the association of serum level of nesfatin-1 and diabetic kidney disease in patients with type 2 diabetes
ArticleStudy of the association of serum level of nesfatin-1 and diabetic kidney disease in patients with type 2 diabetes
ArticleSTUDY OF SERUM OSTEOINDUCTIVE FACTOR AS AN EARLY MARKER OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETIS
ArticleSTUDY OF SERUM OSTEOINDUCTIVE FACTOR AS AN EARLY MARKER OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETIS
ArticleStudy of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes
ArticleStudy of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes
ArticleThe Relationship between Serum Osteopontin level and Parameters of Chronic Kidney Disease – Mineral Bone Disease in Patients on Regular Hemodialysis
ArticleThe Relationship between Serum Osteopontin level and Parameters of Chronic Kidney Disease – Mineral Bone Disease in Patients on Regular Hemodialysis
ArticlePlasma Concentration of Osteopontin as A Predictor of Vascular Calcification in Patients with Diabetic Nephropathy
ArticlePlasma Concentration of Osteopontin as A Predictor of Vascular Calcification in Patients with Diabetic Nephropathy
ArticleSerum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients
ArticleSerum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients